These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32713867)

  • 21. Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis.
    Li SH; Wang QX; Yang ZY; Jiang W; Li C; Sun P; Wei W; Shi M; Guo RP
    World J Gastroenterol; 2017 May; 23(17):3122-3132. PubMed ID: 28533669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 23. Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma.
    Gon H; Kido M; Tanaka M; Kinoshita H; Komatsu S; Tsugawa D; Awazu M; Toyama H; Matsumoto I; Itoh T; Fukumoto T
    Surgery; 2018 Nov; 164(5):1014-1022. PubMed ID: 30093272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma.
    Maegawa FB; Shehorn L; Aziz H; Kettelle J; Jie T; Riall TS
    JAMA Netw Open; 2019 Jan; 2(1):e187142. PubMed ID: 30657533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the surgical outcomes in patients with synchronous versus metachronous multiple hepatocellular carcinoma.
    Midorikawa Y; Takayama T; Higaki T; Aramaki O; Teramoto K; Yoshida N; Mitsuka Y; Tsuji S
    Biosci Trends; 2021 Jan; 14(6):415-421. PubMed ID: 32999134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of cirrhosis on long-term outcomes after liver resection in patients with a single small hepatocellular carcinoma].
    Liang BY; Huang ZY; Liu YA; Hou P; Ji GB; Chen XP
    Zhonghua Wai Ke Za Zhi; 2012 Oct; 50(10):865-9. PubMed ID: 23302452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.
    Pang Q; Bi JB; Xu XS; Liu SS; Zhang JY; Zhou YY; Qu K; Liu C
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1337-46. PubMed ID: 26275082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Platelet Count on Perioperative Bleeding in Patients With Cirrhosis Undergoing Surgical Treatments of Liver Cancer.
    Ronca V; Barabino M; Santambrogio R; Opocher E; Hodson J; Bertolini E; Birocchi S; Piccolo G; Battezzati P; Cattaneo M; Podda GM
    Hepatol Commun; 2022 Feb; 6(2):423-434. PubMed ID: 34716696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant impact of patient age on outcome after liver resection for HCC in cirrhosis.
    Faber W; Stockmann M; Schirmer C; Möllerarnd A; Denecke T; Bahra M; Klein F; Schott E; Neuhaus P; Seehofer D
    Eur J Surg Oncol; 2014 Feb; 40(2):208-13. PubMed ID: 24275202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.
    Liu Y; Wang ZX; Cao Y; Zhang G; Chen WB; Jiang CP
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):266-74. PubMed ID: 27298102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection.
    Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Chen LP
    Medicine (Baltimore); 2018 Jul; 97(29):e11599. PubMed ID: 30024565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low postoperative platelet count is associated with negative outcome after liver resection for hepatocellular carcinoma.
    Riediger C; Bachmann J; Hapfelmeier A; Friess H; Kleeff J; Mueller MW
    Hepatogastroenterology; 2014; 61(133):1313-20. PubMed ID: 25436303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative C-reactive protein/albumin ratio to predict mortality and recurrence of patients with hepatocellular carcinoma after curative resection.
    Ren Y; Fan X; Chen G; Zhou D; Lin H; Cai X
    Med Clin (Barc); 2019 Sep; 153(5):183-190. PubMed ID: 30606506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombocytopenia and the outcomes of hepatectomy for hepatocellular carcinoma: a meta-analysis.
    Zhang Z; Zhang Y; Wang W; Hua Y; Liu L; Shen S; Peng B
    J Surg Res; 2017 Apr; 210():99-107. PubMed ID: 28457347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is portal hypertension a contraindication to hepatic resection?
    Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; Ramacciato G; Grazi GL; Pinna AD
    Ann Surg; 2009 Dec; 250(6):922-8. PubMed ID: 19855258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection.
    Choi WM; Lee JH; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Lee YB; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS; Kim CY; Lee HS
    Liver Int; 2015 Aug; 35(8):1992-2000. PubMed ID: 25556714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence of Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy.
    Zou H; Zhu CZ; Wang C; Wang ZS; Ma X; Han B; Wu LQ
    Am J Med Sci; 2017 Sep; 354(3):262-267. PubMed ID: 28918833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
    Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
    World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The preoperative alkaline phosphatase-to-platelet ratio index is an independent prognostic factor for hepatocellular carcinoma after hepatic resection.
    Yu YQ; Li J; Liao Y; Chen Q; Liao WJ; Huang J
    Medicine (Baltimore); 2016 Dec; 95(51):e5734. PubMed ID: 28002346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum vascular endothelial growth factor per platelet count in hepatocellular carcinoma: correlations with clinical parameters and survival.
    Kim SJ; Choi IK; Park KH; Yoon SY; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Jpn J Clin Oncol; 2004 Apr; 34(4):184-90. PubMed ID: 15121753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.